Digital therapeutics pioneer Pear’s treatments get a second life, a year after bankruptcy
Aug. 22, 2024
Health Tech Correspondent
Over a year after Pear Therapeutics filed for bankruptcy and shut down, its smartphone apps for people with substance use disorder and opioid use disorder are again available to patients.
After acquiring Pear’s Food and Drug Administration-cleared apps, called reSET and reSET-O, in December 2023, virtual addiction treatment company PursueCare this month began offering them to its patients. The company will use the apps to complement its care plans as it develops business opportunities around the treatments.
advertisement
PursueCare’s approach to the relaunch reflects the growing pragmatism among companies hoping to bring prescription digital treatments for psychiatric and other conditions to market. As standalone offerings, these digital therapeutics have struggled to gain adoption by insurers, clinicians, and patients. Increasingly, companies are looking to use apps to support existing care and business models, rather than marketing them as standalone products.
STAT+ Exclusive Story
Already have an account? Log in
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
Monthly
$39
Totals $468 per year
$39/month Get StartedTotals $468 per year
Starter
$20
for 3 months, then $399/year
$20 for 3 months Get StartedThen $399/year
Annual
$399
Save 15%
$399/year Get StartedSave 15%
11+ Users
Custom
Savings start at 25%!
Request A Quote Request A QuoteSavings start at 25%!
2-10 Users
$300
Annually per user
$300/year Get Started$300 Annually per user
View All Plans
To read the rest of this story subscribe to STAT+.
Subscribe Log In health tech, STAT+, Telehealth Submit a correction requestReprints
Newsletter
Tech is transforming health care and life sciences. Our original reporting is here to keep you ahead of the curve.
